OTI BENZODIAZEPINES INTERCEPT MICRO-PLATE EIA MODEL #1110I

Enzyme Immunoassay, Benzodiazepine

ORASURE TECHNOLOGIES, INC.

The following data is part of a premarket notification filed by Orasure Technologies, Inc. with the FDA for Oti Benzodiazepines Intercept Micro-plate Eia Model #1110i.

Pre-market Notification Details

Device IDK013882
510k NumberK013882
Device Name:OTI BENZODIAZEPINES INTERCEPT MICRO-PLATE EIA MODEL #1110I
ClassificationEnzyme Immunoassay, Benzodiazepine
Applicant ORASURE TECHNOLOGIES, INC. 1745 EATON AVE. Bethlehem,  PA  18018 -1799
ContactR. Sam Niedbala
CorrespondentR. Sam Niedbala
ORASURE TECHNOLOGIES, INC. 1745 EATON AVE. Bethlehem,  PA  18018 -1799
Product CodeJXM  
CFR Regulation Number862.3170 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2001-11-23
Decision Date2002-04-17
Summary:summary

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
00608337000252 K013882 000
00608337000245 K013882 000
00608337000238 K013882 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.